Ishan Mehta

机构：Wellcome Sanger Institute · ORCID：0000-0002-2939-917X

发表论文 6 篇 · 总被引 97 次 · h-index 4

代表论文

• Targeting synthetic lethal paralogs in cancer (2023 · Trends in cancer · 被引 59)
• Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma (2022 · The Journal of Pathology · 被引 15)
• The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor types (2025 · Nature Genetics · 被引 14)
• A compendium of synthetic lethal gene pairs defined by extensive combinatorial pan-cancer CRISPR screening (2025 · Genome biology · 被引 4)
• The molecular cartography of malignant and benign sebaceous tumours (2025 · Nature Communications · 被引 2)
• Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma (2023 · European Journal of Cancer · 被引 2)